Interestingly, in the present study, fat wasting was ameliorated in ACVR2B/Fc‐treated tumour mice, suggesting that targeting ACVR2B is sufficient to preserve fat mass along with muscle mass, independent of food consumption. Here, ACVR2B is linked to neoplasm.